In order to invest in Bioverge Funds, investors must meet the criteria of being an accredited investor.
“Accredited investor” has been defined by the Securities and Exchange Commission (SEC) as a test to determine who is eligible to participate in certain private capital market offerings. Generally an individual person is an accredited investor if they: (1) had an income of $200,000 over the last two years (or $300,000 jointly with a spouse or spousal equivalent) and reasonably expect to satisfy the same criteria in the current year, (2) have a net worth of over $1,000,000, either alone or together with a spouse or spousal equivalent (excluding the person’s primary residence) or (3) hold a Series 7, Series 82, or Series 65 financial services license and is in good standing. An individual must be an accredited investor to invest with Bioverge.
Yes, international investors can participate in Bioverge Funds. Our offerings are conducted under the SEC's Regulation D, Rule 506, which allows for participation from both domestic and international investors, provided that they are accredited and comply with the regulations of their respective jurisdictions.
In addition to qualifying as an individual, there are other categories of accredited investors which will satisfy the SEC’s definitions: (1) any entity in which all of the equity owners are accredited investors, or (2) any trust, with total assets in excess of $5 million, not formed specifically to purchase the subject securities, whose purchase is directed by a sophisticated person, or (3) certain entity with total investments in excess of $5 million, not formed to specifically purchase the subject securities.
Bioverge Funds allow investors to access 15 or more companies via a single investment. Our Bioverge Deal-by-Deal products, by comparison, typically invest in a single deal/company. Diversification is a benefit of the Bioverge Funds, as investment risk may be spread across multiple assets. Additionally, investors in Bioverge Funds can access healthcare venture capital opportunities on a wider scale than they might otherwise be able to by making individual investments.
Once you create an account, you will be able to review our investment opportunities. Once you’re ready to invest, our platform will prompt you with any questions necessary to complete your investment documents online and how to fund your investments.
As an investor, you will have access to your portfolio details and you will receive quarterly updates on how your investments are performing. If an investment exit is realized, you will receive associated distribution income or public shares.
Click for important disclosures
Each Bioverge Fund is a limited liability company (LLC) that invests in private securities offerings and is managed by Bioverge. We act as the decision-maker on your behalf, handling the day-to-day operations. As a Bioverge Fund investor, your investment is held in the form of ownership interest in the LLC. If something were to happen to Bioverge (the company), you would still maintain your ownership of the LLC and the entity’s underlying investment holdings.
The sell orders can be placed by any eligible investors in select syndicates that have been approved for secondary transfers.
We expect to first permit sell orders in a syndicate 12 months from the date of an asset’s acquisition. Once this threshold is met, sellers in eligible syndicates will generally have the opportunity to place their interests for sale during quarterly windows established by Bioverge. We expect these windows will take place for approximately 2 weeks in the middle of each quarter.
Sellers can place 100% of their interests for sale in any eligible syndicate. Sellers also have the option to place a portion of their interest for sale. Partial sales require a $25,000 minimum and can then be increased in increments of $5,000. The remaining investment after a partial sale must be at least $10,000. Please contact firstname.lastname@example.org to learn more.
Sellers will have the ability to offer their positions at a specified discount to their “Marked Value,” which is a value determined by Bioverge quarterly. See the definition of “Marked Values” below for more detail. As we continue to refine the Bioverge Secondary Market, we expect to update (and could restrict) the range of prices that positions can be offered at.
In order to facilitate an efficient experience on the Bioverge Secondary Market, we do not currently accept orders at prices that vary from the specified discount to the Marked Value.